Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8WE6 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
| 8WE6 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
| 8WE6 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
| 8FHS | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
| 8FHS | P54284 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
| 8FHS | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
| 8WE7 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE7 | P22947 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE7 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE7 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
| 8WE8 | Q13936 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE8 | P22947 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE8 | P54284 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 8WE8 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
| 7UHG | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
| 7UHG | P54284 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
| 7UHG | P54289 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
| 8E5B | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E59 | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 7UHF | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
| 7UHF | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
| 7UHF | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
| 8E5A | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54284 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54289 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 7B00 | Q9UHI5 | Human LAT2-4F2hc complex in the apo-state | |
| 7B00 | P08195 | Human LAT2-4F2hc complex in the apo-state | |
| 1XOI | P06737 | Human Liver Glycogen Phosphorylase A complexed with Chloroindoloyl glycine amide | |
| 3SRD | P14618 | Human M2 pyruvate kinase in complex with fructose 1-6 bisphosphate and Oxalate. | |
| 7KZ1 | O95243 | Human MBD4 glycosylase domain bound to DNA containing an abasic site | |
| 6TM2 | Q02817 | Human MUC2 AAs 21-1397 | |
| 7A5O | Q02817 | Human MUC2 AAs 21-1397 | |
| 3ZS0 | P05164 | Human Myeloperoxidase inactivated by TX2 | |
| 3ZS1 | P05164 | Human Myeloperoxidase inactivated by TX5 | |
| 6DXX | Q02083 | Human N-acylethanolamine-hydrolyzing acid amidase (NAAA) in complex with non-covalent benzothiazole-piperazine inhibitor ARN19702, in presence of Triton X-100 | |
| 6DXW | Q02083 | Human N-acylethanolamine-hydrolyzing acid amidase (NAAA) precursor (C126A) | |
| 7VFS | Q00975 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, apo state | |
| 7VFS | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, apo state | |
| 7VFS | Q02641 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, apo state | |
| 7VFW | Q00975 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to CaV2.2-blocker1 | |
| 7VFW | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to CaV2.2-blocker1 | |
| 7VFW | Q02641 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to CaV2.2-blocker1 | |
| 7VFV | Q00975 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to PD173212 | |
| 7VFV | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to PD173212 | |
| 7VFV | Q02641 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to PD173212 | |
| 7VFU | Q00975 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to ziconotide |
